InMode (INMD) Share-based Compensation (2018 - 2026)
InMode (INMD) posted quarterly Share-based Compensation of $2.7 million for Q1 2026, up 7.19% year-on-year from $2.5 million in Q1 2025, and up 8.0% on a QoQ basis from $2.5 million in Q4 2025.
InMode (INMD) Share-based Compensation (2018 - 2026) Analysis & Trends
InMode (INMD) has reported Share-based Compensation for 9 consecutive years, with $2.7 million the latest figure, recorded in Q1 2026.
- Quarterly Share-based Compensation rose 7.19% year-over-year to $2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.3 million (down 25.11% YoY) and the FY2025 annual result came in at $11.1 million, down 32.82% from the prior year.
- Share-based Compensation grew to $2.7 million in Q1 2026 per INMD's latest filing, from $2.5 million in the prior quarter.
- Over the last five years, Share-based Compensation for INMD reached as high as $7.9 million in Q3 2022 and fell as low as $2.5 million in Q4 2025.
- A 5-year average of $4.6 million and a median of $4.0 million in 2024 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2022 — Share-based Compensation soared 146.15% — and 2024, when it tumbled 45.48%.
- Year by year, Share-based Compensation stood at $7.1 million in 2022, then slipped by 11.56% to $6.3 million in 2023, then slumped by 45.48% to $3.4 million in 2024, then slipped by 27.5% to $2.5 million in 2025, then advanced by 8.0% to $2.7 million in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $2.7 million, $2.5 million, and $2.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InMode | 956,721.10 | -479.17 Mn | 61.55 Mn | 2.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.70 Mn |
| Mar 31, 2026 | 2.70 Mn |
| Dec 31, 2025 | 2.50 Mn |
| Dec 31, 2025 | 2.50 Mn |
| Sep 30, 2025 | 2.70 Mn |
| Sep 30, 2025 | 2.70 Mn |
| Jun 30, 2025 | 3.42 Mn |
| Jun 30, 2025 | 3.42 Mn |
| Mar 31, 2025 | 2.52 Mn |
| Mar 31, 2025 | 2.52 Mn |
| Dec 31, 2024 | 3.45 Mn |
| Dec 31, 2024 | 3.45 Mn |
| Sep 30, 2024 | 3.98 Mn |
| Sep 30, 2024 | 3.98 Mn |
| Jun 30, 2024 | 5.16 Mn |
| Jun 30, 2024 | 5.16 Mn |
| Mar 31, 2024 | 3.98 Mn |
| Mar 31, 2024 | 3.98 Mn |
| Dec 31, 2023 | 6.32 Mn |
| Dec 31, 2023 | 6.32 Mn |